Pharmaniaga
Pharmaniaga Berhad, a prominent player in the pharmaceutical industry, is headquartered in Malaysia (MY) and operates extensively across Southeast Asia. Founded in 1994, the company has established itself as a leading provider of generic pharmaceuticals, over-the-counter products, and healthcare solutions. With a commitment to quality and innovation, Pharmaniaga offers a diverse range of products, including prescription medications and vaccines, which are distinguished by their adherence to stringent regulatory standards. The company has achieved significant milestones, including partnerships with government health agencies and a robust distribution network that enhances its market position. Recognised for its contributions to public health, Pharmaniaga continues to expand its footprint, ensuring access to essential medicines while maintaining a focus on sustainability and community welfare.
DitchCarbon Score
How does Pharmaniaga's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmaniaga's score of 27 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmaniaga's reported carbon emissions
In 2023, Pharmaniaga, headquartered in Malaysia, reported total carbon emissions of approximately 36,440,040 kg CO2e, comprising 6,576,490 kg CO2e from Scope 1 and 29,081,550 kg CO2e from Scope 2 emissions. This marks a notable increase from 2022, where emissions were about 30,965,510 kg CO2e, with 6,044,780 kg CO2e from Scope 1 and 25,051,730 kg CO2e from Scope 2. Pharmaniaga has not disclosed any Scope 3 emissions data, indicating a potential area for future reporting and improvement. The company has not set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges, which suggests a need for enhanced climate commitments in line with industry standards. The emissions data is sourced directly from Pharmaniaga Berhad, with no cascading from a parent or related organization. As the pharmaceutical industry increasingly focuses on sustainability, Pharmaniaga's current emissions profile and lack of defined reduction strategies highlight an opportunity for the company to strengthen its climate commitments and align with global best practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 9,257,950 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 28,245,640 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmaniaga is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
